FDA Approves Tessie: The First Drug to Treat Both Noise Aversion and Separation Anxiety in Dogs

On May 6, 2026, the FDA approved tasipimidine oral solution, sold under the name Tessie, making it the first medication ever cleared to treat two of the most common fear-based conditions in dogs at once: noise aversion and separation anxiety.

That's worth pausing on. These two conditions are, individually, already among the most distressing things a dog owner deals with. Together, they're exhausting. And until now, treatment options have been fragmented at best.

What Tessie Actually Is

Tasipimidine is an alpha-2 adrenergic agonist, which means it works by calming the nervous system's stress response rather than broadly sedating the dog. The distinction matters, because one of the long-standing frustrations with older situational anxiety medications was that they could make a dog drowsy and disconnected without actually reducing the fear underneath.

This approval covers both noise aversion (think fireworks, thunderstorms, the neighbour's drill) and separation anxiety, which is a significant step. Previous FDA-approved options tended to address one or the other. Sileo, for instance, approved back in 2016, was specifically for noise aversion. Clomicalm for separation anxiety. Having both indications in a single medication gives vets and owners a more straightforward conversation to have.

It's an oral solution, which will matter to anyone who has ever tried to get a panicking dog to take a tablet thirty minutes before a thunderstorm they didn't know was coming.

Why This Matters More Than It Might Seem

Separation anxiety affects an estimated 14 to 17 percent of pet dogs, according to a 2020 review published in Frontiers in Veterinary Science by Flavia de Oliveira Salles and colleagues. Noise aversion numbers are harder to pin down, but surveys of dog owners consistently put noise fears in the top three behavioural complaints alongside aggression and house-training issues.

The overlap between the two is also significant. Dogs with separation anxiety are disproportionately likely to also have noise phobias, possibly because both conditions share the same underlying hyperreactivity to perceived threat. Treating one often improves the other, and a medication designed with both in mind reflects a more accurate picture of how anxiety actually presents in dogs, rather than the tidy categorical boxes we put it in for diagnostic convenience.

What This Doesn't Replace

Medication alone rarely solves behavioural problems rooted in fear. Most behaviourists and vets working in this space are fairly consistent on this: a drug like Tessie is best understood as a tool that lowers the emotional floor enough for a dog to actually learn. Desensitisation and counter-conditioning work better when a dog isn't already past the threshold where learning is possible.

So if your dog loses it at the sound of a distant firework, Tessie might bring that threshold up enough that training can actually stick. But you still need the training.

This is also a prescription medication. You can't pick it up without a vet conversation, which is appropriate given that individual dogs have different health histories, contraindications, and anxiety profiles. The alpha-2 mechanism also means blood pressure effects are a consideration, particularly in older dogs or those with cardiovascular issues.

What to Ask Your Vet

If your dog has documented noise aversion or separation anxiety, here are the things worth raising when Tessie comes up:

• Whether your dog's anxiety has been formally assessed, or whether what you're seeing could have another root cause (pain, for instance, is a common and underdiagnosed driver of anxiety-adjacent behaviour in dogs)
• Your dog's current medications or supplements, since alpha-2 agonists can interact with sedatives and some cardiac drugs
• What the dosing window looks like and whether that's practical for your dog's specific triggers (separation anxiety, unlike a thunderstorm, doesn't always give you advance notice)
• Whether a combined approach with a trainer or veterinary behaviourist is part of the plan

Tracking Whether It's Working

One of the underappreciated challenges with anxiety medications in dogs is that the feedback loop is slow and imprecise. You give the medication, you observe the dog, you try to work out whether things are better. But anxiety symptoms are often episodic and context-dependent, which makes it genuinely hard to know if a change in behaviour is the drug working, the dog having a quieter week, or something else entirely.

This is where systematic tracking makes a real difference. Logging specific episodes, with notes on context, duration, intensity, and what preceded the event, gives you and your vet something concrete to work with rather than a general impression. Tailo's episode tracking is built for exactly this kind of documentation, and if your dog is starting a new medication, having a consistent record from before and after is far more useful than memory alone.

The Bigger Picture

The FDA approval of Tessie is, in a small but real way, evidence that canine behavioural medicine is maturing. There was a time when separation anxiety was dismissed as the dog being "attention-seeking" and noise phobia was just accepted as a quirk you managed with distraction. The scientific literature has shifted considerably, and regulatory approvals like this one reflect how far the field has come in understanding these as genuine neurological fear responses, not training failures.

That doesn't mean every anxious dog needs medication. Plenty of dogs do well with environmental management, predictable routines, and structured desensitisation work. But for dogs at the more severe end, having a better pharmacological option is a meaningful development.

If your dog has been struggling with fireworks season, separation distress, or both, the conversation with your vet just got a new option worth putting on the table.